Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder

NCT03526354 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder
Substance Use Disorders

Interventions

DRUG: Brexpiprazole
OTHER: Treatment as Usual

Sponsor

University of Massachusetts, Worcester

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]